Pomalidomide, Rituximab and Orelabrutinib Combined With Polatuzumab Vedotin in the Treatment of Newly Diagnosed Elderly Patients With DLBCL

NCT07072208 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B-Cell Lymphoma

Interventions

DRUG: Induction therapy-Pro regimen
DRUG: Consolidation therapy-Pro-pola regimen

Sponsor

The First Affiliated Hospital of Soochow University